Literature DB >> 31179620

Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder.

Allison C Nugent1,2, Cristan Farmer1, Jennifer W Evans1, Sam L Snider1, Dipavo Banerjee1, Carlos A Zarate1.   

Abstract

Major depressive disorder (MDD) is highly prevalent and associated with considerable morbidity, yet its pathophysiology remains only partially understood. While numerous studies have investigated the neurobiological correlates of MDD, most have used only a single neuroimaging modality. In particular, diffusion tensor imaging (DTI) studies have failed to yield uniform results. In this context, examining key tracts and using information from multiple neuroimaging modalities may better characterize potential abnormalities in the MDD brain. This study analyzed data from 30 participants with MDD and 26 healthy participants who underwent DTI, magnetic resonance spectroscopy (MRS), resting-state functional magnetic resonance imaging (fMRI), and magnetoencephalography (MEG). Tracts connecting the subgenual anterior cingulate cortex (sgACC) and the left and right amygdala, as well as connections to the left and right hippocampus and thalamus, were examined as target areas. Reduced fractional anisotropy (FA) was observed in the studied tracts. Significant differences in the correlation between medial prefrontal glutamate concentrations and FA were also observed between MDD and healthy participants along tracts connecting the sgACC and right amygdala; healthy participants exhibited a strong correlation but MDD participants showed no such relationship. In the same tract, a correlation was observed between FA and subsequent antidepressant response to ketamine infusion in MDD participants. Exploratory models also suggested group differences in the relationship between DTI, fMRI, and MEG measures. This study is the first to combine MRS, DTI, fMRI, and MEG data to obtain multimodal indices of MDD and antidepressant response and may lay the foundation for similar future analyses. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  diffusion tensor imaging; functional magnetic resonance imaging; magnetic resonance spectroscopy; magnetoencephalography; major depressive disorder; multimodal

Mesh:

Year:  2019        PMID: 31179620      PMCID: PMC6677619          DOI: 10.1002/hbm.24679

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  40 in total

1.  Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder.

Authors:  Allison C Nugent; Cristan Farmer; Jennifer W Evans; Sam L Snider; Dipavo Banerjee; Carlos A Zarate
Journal:  Hum Brain Mapp       Date:  2019-06-09       Impact factor: 5.038

2.  Incapacity to control emotion in major depression may arise from disrupted white matter integrity and OFC-amygdala inhibition.

Authors:  Kai-Zhong Zheng; Hua-Ning Wang; Jian Liu; Yi-Bin Xi; Liang Li; Xi Zhang; Jia-Ming Li; Hong Yin; Qing-Rong Tan; Hong-Bing Lu; Bao-Juan Li
Journal:  CNS Neurosci Ther       Date:  2018-01-24       Impact factor: 5.243

3.  Quantitative tract-specific measures of uncinate and cingulum in major depression using diffusion tensor imaging.

Authors:  Aifeng Zhang; Alex Leow; Olusola Ajilore; Melissa Lamar; Shaolin Yang; Josh Joseph; Jennifer Medina; Liang Zhan; Anand Kumar
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

4.  Detection of glutamate, glutamine, and glutathione by radiofrequency suppression and echo time optimization at 7 tesla.

Authors:  Li An; Shizhe Li; James B Murdoch; Maria Ferraris Araneta; Christopher Johnson; Jun Shen
Journal:  Magn Reson Med       Date:  2014-02-28       Impact factor: 4.668

Review 5.  The subgenual anterior cingulate cortex in mood disorders.

Authors:  Wayne C Drevets; Jonathan Savitz; Michael Trimble
Journal:  CNS Spectr       Date:  2008-08       Impact factor: 3.790

6.  Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration.

Authors:  Jennifer W Evans; Joanna Szczepanik; Nancy Brutsché; Lawrence T Park; Allison C Nugent; Carlos A Zarate
Journal:  Biol Psychiatry       Date:  2018-02-15       Impact factor: 13.382

7.  Structural connectivity and response to ketamine therapy in major depression: A preliminary study.

Authors:  Megha M Vasavada; Amber M Leaver; Randall T Espinoza; Shantanu H Joshi; Stephanie N Njau; Roger P Woods; Katherine L Narr
Journal:  J Affect Disord       Date:  2015-11-18       Impact factor: 4.839

8.  7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study.

Authors:  Jennifer W Evans; Níall Lally; Li An; Ningzhi Li; Allison C Nugent; Dipavo Banerjee; Sam L Snider; Jun Shen; Jonathan P Roiser; Carlos A Zarate
Journal:  Neuropsychopharmacology       Date:  2018-04-05       Impact factor: 7.853

9.  A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDER.

Authors:  Doreen M Olvet; Lauren Delaparte; Fang-Cheng Yeh; Christine DeLorenzo; Patrick J McGrath; Myrna M Weissman; Phillip Adams; Maurizio Fava; Thilo Deckersbach; Melvin G McInnis; Thomas J Carmody; Crystal M Cooper; Benji T Kurian; Hanzhang Lu; Marisa S Toups; Madhukar H Trivedi; Ramin V Parsey
Journal:  Depress Anxiety       Date:  2015-10-19       Impact factor: 6.505

10.  Effects of a Polymorphism of the Neuronal Amino Acid Transporter SLC6A15 Gene on Structural Integrity of White Matter Tracts in Major Depressive Disorder.

Authors:  Sunyoung Choi; Kyu-Man Han; June Kang; Eunsoo Won; Hun Soo Chang; Woo Suk Tae; Kyu Ri Son; Su-Jin Kim; Min-Soo Lee; Byung-Joo Ham
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

View more
  15 in total

1.  Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder.

Authors:  Allison C Nugent; Cristan Farmer; Jennifer W Evans; Sam L Snider; Dipavo Banerjee; Carlos A Zarate
Journal:  Hum Brain Mapp       Date:  2019-06-09       Impact factor: 5.038

2.  Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment.

Authors:  Christoph Kraus; Anahit Mkrtchian; Bashkim Kadriu; Allison C Nugent; Carlos A Zarate; Jennifer W Evans
Journal:  Neuropsychopharmacology       Date:  2020-01-29       Impact factor: 7.853

Review 3.  Neurobiological biomarkers of response to ketamine.

Authors:  Bashkim Kadriu; Elizabeth D Ballard; Ioline D Henter; Stephen Murata; Nimesha Gerlus; Carlos A Zarate
Journal:  Adv Pharmacol       Date:  2020-06-18

4.  Promising Neuroimaging Biomarkers in Depression.

Authors:  Chien-Han Lai
Journal:  Psychiatry Investig       Date:  2019-09-23       Impact factor: 2.505

5.  Protocol on transcranial alternating current stimulation for the treatment of major depressive disorder: a randomized controlled trial.

Authors:  Hong-Xing Wang; Kun Wang; Wen-Rui Zhang; Wen-Feng Zhao; Xiao-Tong Yang; Li Wang; Mao Peng; Zhi-Chao Sun; Qing Xue; Yu Jia; Ning Li; Kai Dong; Qian Zhang; Shu-Qin Zhan; Bao-Quan Min; Chun-Qiu Fan; Ai-Hong Zhou; Hai-Qing Song; Lu Yin; Tian-Mei Si; Jing Huang; Jie Lu; Hai-Xia Leng; Wei-Jun Ding; Yuan Liu; Tian-Yi Yan; Yu-Ping Wang
Journal:  Chin Med J (Engl)       Date:  2020-01-05       Impact factor: 2.628

6.  Transient effects of multi-infusion ketamine augmentation on treatment-resistant depressive symptoms in patients with treatment-resistant bipolar depression - An open-label three-week pilot study.

Authors:  Chuanjun Zhuo; Feng Ji; Hongjun Tian; Lina Wang; Feng Jia; Deguo Jiang; Ce Chen; Chunhua Zhou; Xiaodong Lin; Jingjing Zhu
Journal:  Brain Behav       Date:  2020-07-03       Impact factor: 2.708

7.  Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine's antidepressant effects.

Authors:  Valerie J Sydnor; Amanda E Lyall; Suheyla Cetin-Karayumak; Joey C Cheung; Julia M Felicione; Oluwaseun Akeju; Martha E Shenton; Thilo Deckersbach; Dawn F Ionescu; Ofer Pasternak; Cristina Cusin; Marek Kubicki
Journal:  Transl Psychiatry       Date:  2020-12-15       Impact factor: 6.222

Review 8.  Biomarkers of ketamine's antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology.

Authors:  Alexandra A Alario; Mark J Niciu
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-05-31

Review 9.  Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?

Authors:  Nazia Karsan; Peter J Goadsby
Journal:  Front Hum Neurosci       Date:  2021-06-03       Impact factor: 3.169

10.  Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study.

Authors:  Raquel Pascual-Antón; Arantxa Blasco-Serra; Emma Muñoz-Moreno; Fuencisla Pilar-Cuéllar; Emilio Garro-Martínez; Eva Florensa-Zanuy; Xavier López-Gil; Víctor M Campa; Guadalupe Soria; Albert Adell
Journal:  Brain Struct Funct       Date:  2021-08-07       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.